Aurobindo Pharma share price up 0.5 per cent

The scrip has declined 33.55 per cent in the last one year till date, while the 30-share index has gained 2.16 per cent during the same period.

The stock’s 52-week high price stood at Rs 730.0 and the 52-week low price at Rs 429.3.

Trading volume on the counter stood at 5,838 shares, while it quoted a price-to-earnings ratio of 12.35, an EPS value of 36.03 and a price-to-book value of 1.59. In the Nifty50 pack, 34 stocks traded in the green, while 16 stocks were in the red.

Promoter/FII Holding
Promoters held 51.83 per cent stake in the company as of 31-Dec-2022, while foreign institutional investors and mutual funds’ ownership stood at 22.43 per cent and 7.5 per cent, respectively.

Key Financials
For the quarter ended 30-Sep-2022, the company reported consolidated sales of Rs 5796.56 crore, down 7.65 per cent from the previous quarter’s Rs 6276.54 crore and down 4.01 per cent from the year-ago quarter’s Rs 6038.5 crore. The company reported net profit of Rs 409.45 crore for the latest quarter.

Technical Indicators
The MACD signalled a bullish bias on the counter. The MACD is known for signalling trend reversals in traded securities or indices. It is the difference between the 26-day and 12-day exponential moving averages. A nine-day exponential moving average, called the signal line, is plotted on top of the MACD to reflect “buy” or “sell” opportunities. When the MACD crosses below the signal line, it gives a bearish signal, indicating that the price of the security may see a downward movement and vice versa.